TELADOC HEALTH, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
TELADOC HEALTH, INC. (TDOC) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $9.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-30
- TELADOC HEALTH, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $9.71M, a 59.94% decline year-over-year.
- TELADOC HEALTH, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $15.14M, a 45.42% decline year-over-year.
- TELADOC HEALTH, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $17.28M, a 42.31% decline year-over-year.
- TELADOC HEALTH, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $18.69M, a 49.48% decline year-over-year.
- TELADOC HEALTH, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $87.96M, a 44.56% decline from fiscal 2024.
- TELADOC HEALTH, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $158.67M, a 28.20% decline from fiscal 2023.
- TELADOC HEALTH, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $220.99M, a 6.40% decline from fiscal 2022.
- TELADOC HEALTH, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $236.09M, a 25.23% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.71M 10-Q · filed 2026-07-30 | $24.86M 10-Q · filed 2026-07-30 | $42.14M derived: sum of 3 quarters · filed 2026-07-30 | $60.83M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $15.14M 10-Q · filed 2026-04-30 | $32.42M derived: sum of 2 quarters · filed 2026-04-30 | $51.12M derived: sum of 3 quarters · filed 2026-04-30 | $75.36M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $17.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $35.98M derived: sum of 2 quarters · filed 2026-02-26 | $60.22M derived: sum of 3 quarters · filed 2026-07-30 | $87.96M 10-K · filed 2026-02-26 |
| 2025-09-30 | $18.69M 10-Q · filed 2025-10-30 | $42.94M derived: sum of 2 quarters · filed 2026-07-30 | $70.68M 10-Q · filed 2025-10-30 | $100.64M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $24.25M 10-Q · filed 2026-07-30 | $51.99M 10-Q · filed 2026-07-30 | $81.94M derived: sum of 3 quarters · filed 2026-07-30 | $118.94M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $27.74M 10-Q · filed 2026-04-30 | $57.70M derived: sum of 2 quarters · filed 2026-04-30 | $94.69M derived: sum of 3 quarters · filed 2026-04-30 | $140.19M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $29.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $66.95M derived: sum of 2 quarters · filed 2026-02-26 | $112.45M derived: sum of 3 quarters · filed 2026-02-26 | $158.67M 10-K · filed 2026-02-26 |
| 2024-09-30 | $37.00M 10-Q · filed 2025-10-30 | $82.50M derived: sum of 2 quarters · filed 2025-10-30 | $128.72M 10-Q · filed 2025-10-30 | $180.39M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $45.50M 10-Q · filed 2025-07-30 | $91.72M 10-Q · filed 2025-07-30 | $143.39M derived: sum of 3 quarters · filed 2026-02-26 | $201.37M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $46.22M 10-Q · filed 2025-05-01 | $97.90M derived: sum of 2 quarters · filed 2026-02-26 | $155.87M derived: sum of 3 quarters · filed 2026-02-26 | $216.58M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $51.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $109.65M derived: sum of 2 quarters · filed 2026-02-26 | $170.35M derived: sum of 3 quarters · filed 2026-02-26 | $220.99M 10-K · filed 2026-02-26 |
| 2023-09-30 | $57.97M 10-Q · filed 2024-10-31 | $118.68M derived: sum of 2 quarters · filed 2024-10-31 | $169.31M 10-Q · filed 2024-10-31 | $224.90M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $60.71M 10-Q · filed 2024-08-01 | $111.34M 10-Q · filed 2024-08-01 | $166.93M derived: sum of 3 quarters · filed 2025-02-27 | $227.15M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $50.63M 10-Q · filed 2024-04-26 | $106.22M derived: sum of 2 quarters · filed 2025-02-27 | $166.44M derived: sum of 3 quarters · filed 2025-02-27 | $222.76M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $55.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $115.81M derived: sum of 2 quarters · filed 2025-02-27 | $172.13M derived: sum of 3 quarters · filed 2025-02-27 | $236.09M 10-K · filed 2025-02-27 |
| 2022-09-30 | $60.22M 10-Q · filed 2023-10-27 | $116.54M derived: sum of 2 quarters · filed 2023-10-27 | $180.50M 10-Q · filed 2023-10-27 | $246.24M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $56.32M 10-Q · filed 2023-07-28 | $120.28M 10-Q · filed 2023-07-28 | $186.01M derived: sum of 3 quarters · filed 2024-02-23 | $260.32M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $63.96M 10-Q · filed 2023-05-02 | $129.70M derived: sum of 2 quarters · filed 2024-02-23 | $204.01M derived: sum of 3 quarters · filed 2024-02-23 | $289.72M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $65.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $140.04M derived: sum of 2 quarters · filed 2024-02-23 | $225.76M derived: sum of 3 quarters · filed 2024-02-23 | $315.76M 10-K · filed 2024-02-23 |
| 2021-09-30 | $74.31M 10-Q · filed 2022-11-02 | $160.03M derived: sum of 2 quarters · filed 2022-11-02 | $250.03M 10-Q · filed 2022-11-02 | $666.49M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $85.72M 10-Q · filed 2022-08-03 | $175.72M 10-Q · filed 2022-08-03 | $592.18M derived: sum of 3 quarters · filed 2023-03-01 | $613.36M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $90.00M 10-Q · filed 2022-05-02 | $506.46M derived: sum of 2 quarters · filed 2023-03-01 | $527.64M derived: sum of 3 quarters · filed 2023-03-01 | $549.78M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $416.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $437.64M derived: sum of 2 quarters · filed 2023-03-01 | $459.78M derived: sum of 3 quarters · filed 2023-03-01 | $478.20M 10-K · filed 2023-03-01 |
| 2020-09-30 | $21.18M 10-Q · filed 2021-11-01 | $43.32M derived: sum of 2 quarters · filed 2021-11-01 | $61.74M 10-Q · filed 2021-11-01 | |
| 2020-06-30 | $22.14M 10-Q · filed 2021-08-02 | $40.56M derived: sum of 2 quarters · filed 2021-08-02 | ||
| 2020-03-31 | $18.42M 10-Q · filed 2021-08-02 | |||
| 2019-12-31 | $67.28M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $17.83M 10-Q · filed 2020-11-06 | $35.20M derived: sum of 2 quarters · filed 2020-11-06 | $48.72M derived: sum of 3 quarters · filed 2020-11-06 | |
| 2019-06-30 | $17.37M 10-Q · filed 2020-11-06 | $30.89M derived: sum of 2 quarters · filed 2020-11-06 | ||
| 2019-03-31 | $13.52M 10-Q · filed 2020-11-06 | |||
| 2018-12-31 | $43.77M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $12.20M 10-Q · filed 2019-10-30 | $23.25M derived: sum of 2 quarters · filed 2019-10-30 | $31.09M derived: sum of 3 quarters · filed 2019-10-30 | $48.05M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $11.06M 10-Q · filed 2019-10-30 | $18.89M derived: sum of 2 quarters · filed 2019-10-30 | $35.86M derived: sum of 3 quarters · filed 2020-02-26 | $41.83M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $7.83M 10-Q · filed 2019-10-30 | $24.80M derived: sum of 2 quarters · filed 2020-02-26 | $30.77M derived: sum of 3 quarters · filed 2020-02-26 | $35.33M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $16.97M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $22.93M derived: sum of 2 quarters · filed 2020-02-26 | $27.50M derived: sum of 3 quarters · filed 2020-02-26 | $30.60M 10-K · filed 2020-02-26 |
| 2017-09-30 | $5.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $10.53M derived: sum of 2 quarters · filed 2017-11-01 | $13.63M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $4.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $7.66M 10-Q · filed 2017-08-02 | ||
| 2017-03-31 | $3.10M 10-Q · filed 2017-05-08 | |||
| 2016-12-31 | $7.72M 10-K · filed 2019-02-27 | |||
| 2015-12-31 | $3.08M 10-K · filed 2018-02-27 | |||
| 2014-12-31 | $533.00K 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |